Funding for this research was provided by:
Eli Lilly and Company
National Institute for Health Research
Received: 26 March 2020
Accepted: 19 August 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: Analysis of data from Guy’s RA Centre was approved by the Health Research Authority (IRAS project ID 209418). As the Guy’s RA Centre comprises routinely collected anonymised healthcare data, written consent was not required.
: Not applicable.
: ICS has no competing interests; BK has received support from AbbVie, Arthritis Support UK, Eli Lilly and Company, Janssen, Novartis, F. Hoffmann-La Roche and UCB; JM is an employee of Eli Lilly and Company; JB was an employee of Eli Lilly and Company at the time of the study but is now an employee of Gilead Sciences.